Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Roche discloses new DDR1 inhibitors

Aug. 28, 2017

Lilly discovers novel phosphodiesterase PDE1 inhibitors

Aug. 25, 2017

TFAM overexpression rescues sperm defects in infertile mtDNA mutator mice

Aug. 22, 2017

Avadel and Serenity enter into exclusive negotiations for Noctiva

Aug. 18, 2017

Taiho Pharmaceutical begins enrolling patients in phase II study of TAC-302

Aug. 11, 2017

FDA grants orphan drug designation for blisibimod as treatment of IgA nephropathy

Aug. 10, 2017

Clearance for first-in-human study of ORBCEL-M for diabetic kidney disease

Aug. 7, 2017

FDA grants orphan drug designation to OMS-721 for IgA nephropathy

Aug. 7, 2017

Quark Pharmaceuticals reports positive results from QPI-1002 phase II study

July 28, 2017

Encouraging phase IIa results for DMX-200 in patients with proteinuria

July 14, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...